Madrigal Pharmaceuticals MDGL
NASDAQ MDGL
$508.37 -1.07 (-0.21%)
As of: Sep 30, 2026 · 11:43 AM EDT

Madrigal Pharmaceuticals (MDGL) Total Non-Current Liabilities (2010 - 2026)

Updated

Madrigal Pharmaceuticals (MDGL) recorded Total Non-Current Liabilities of $346.72 million in Q2 2026, up 182.1% from $122.9 million a year earlier and up 0.3% from the prior quarter.

Analysis

Madrigal Pharmaceuticals (MDGL) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Madrigal Pharmaceuticals reported Total Non-Current Liabilities of $346.61 million, up 192.3% from FY2024.

  • Annual Total Non-Current Liabilities has increased for three straight years, with a five-year compound annual growth rate of 274.9% (FY2020 to FY2025).
  • Across earlier years, Total Non-Current Liabilities came in at $118.59 million in FY2024 (+1.6%), $116.67 million in FY2023 (+136.7%), $49.29 million in FY2022 and $387,000 in FY2021 (-17.3%).
  • The Q2 2026 figure is the highest quarterly Total Non-Current Liabilities in data going back to Q4 2010.
  • On a year-over-year basis, Total Non-Current Liabilities has increased for 13 consecutive quarters, with growth averaging 95.9% over the last eight quarters.
  • Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 192.3% in Q4 2025, against a decline of 26.9% in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $345.61 million (Q1 2026), $346.61 million (Q4 2025) and $345.32 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Madrigal Pharmaceuticals 15.07 Bn 11.32 Bn - 346.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 346.72 Mn
Mar 31, 2026 345.61 Mn
Dec 31, 2025 346.61 Mn
Sep 30, 2025 345.32 Mn
Jun 30, 2025 122.90 Mn
Mar 31, 2025 118.76 Mn
Dec 31, 2024 118.59 Mn
Sep 30, 2024 118.26 Mn
Jun 30, 2024 117.51 Mn
Mar 31, 2024 117.18 Mn
Dec 31, 2023 116.67 Mn
Sep 30, 2023 116.05 Mn
Jun 30, 2023 99.25 Mn
Mar 31, 2023 83.97 Mn
Dec 31, 2022 49.29 Mn
Sep 30, 2022 49.05 Mn
Jun 30, 2022 48.85 Mn
Mar 31, 2022 283,000.00
Dec 31, 2021 387,000.00
Sep 30, 2021 491,000.00
API Access

Madrigal Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=MDGL&period=max&api_key=YOUR_API_KEY